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Sir, Idiopathic uveal effusion syndrome causing unilateral acute angle closure in a pseudophakic patient Pseudophakic angle closure is a rare occurrence. Most frequently it occurs secondary to pupil block with iris bombe, capsular bag distention syndrome, or aqueous misdirection, with an anterior shift of the iris-lens diaphragm. We present a case of acute angle closure in a pseudophakic patient without pupil block caused by an idiopathic uveal effusion syndrome (IUES).
Case report
A pseudophakic 65-year-old lady presented with a 1-day history of pain around the right eye approximately 2 years after uncomplicated cataract surgery. Examination revealed a visual acuity of 6/9 and intraocular pressure (IOP) of 32 mm Hg. The anterior chamber was quiet with no posterior synechiae or axial shallowing. Peripheral iridocorneal contact was visible. Gonioscopy showed 3601 angle closure (Figure 1 ). The IOL was in the bag, with the posterior capsule apposed to its posterior surface. Fundal examination showed folds in the choroid without serous retinal detachment. The patient was normotensive at presentation and not on antihypertensives. An ultrasound B-scan and OCT confirmed annular choroidal effusions and angle closure ( Figure 2 ). There was no evidence of posterior scleritis, scleral thickening, or choroidal masses. The patient was not nanophthalmic and a CT scan of the orbits showed no masses, myositis, or vascular malformations. She had a background of diabetes and epilepsy. There were no recent changes to her medications that comprised metformin 500 mg BD, pregabalin 50 mg TDS, repaglinide 1 mg BD, and lamotrigine 100 mg BD, none of which is known to cause uveal effusion. She had never taken topiramate. Full blood count, renal, liver and thyroid function tests, autoantibody screening, immunoglobulins, and plasma electrophoresis were unremarkable.
The patient was treated with a single dose of acetazolamide 500 mg, topical atropine 1%, and timolol 0.25%. The drainage angle opened with cycloplegia and the IOP was lowered to 13 mm Hg. Consideration of sclerectomy was made, but the condition fully resolved over the next month without intervention. A fluorescein angiogram performed 2 weeks after presentation showed no evidence of vasculitis.
Comment
Spontaneous uveal effusions are rare and can be caused by inflammation (scleritis/myositis), infection, malignancy, or an idiosyncratic response to drugs (when they are typically bilateral).
1,2 IUES is a diagnosis of exclusion and typically occurs in middle-aged men. The pathogenesis remains controversial and is thought to be related to abnormalities in the sclera resulting in albumin accumulation. 3 To our knowledge unilateral pseudophakic acute angle closure secondary to IUES has not been reported. Pseudophakic angle closure is rare and can be caused by a variety of different mechanisms. 4 Careful assessment of peripheral iris configuration and symmetry of anterior chamber depth point to the diagnosis. Sir, Association between intraocular pressure and adherence: is there one?
M Bhogal
The paper by Ajit et al 1 that was recently published in Eye described a new methodology of graphically presenting adherence data, using an electronic dosing monitor. The concept of using such a device to provide meaningful, graphical information is potentially favourable to the clinician in identifying patterns of adherence. However, the idea of collecting this information for all patients is probably unrealistic and unlikely to be cost-effective.
Lowering intraocular pressure (IOP) to reduce or halt the progression of visual field loss is the only currently available intervention for patients with glaucoma. Measuring IOP to assess efficacy has been standard practice ever since topical anti-glaucoma therapy was commenced. If a therapeutic regimen is adhered to, a reduction in IOP would be expected on repeat measurement a priori. Theoretically, therapeutic outcome would be both an objective and a practical measure of adherence. However, to date there is no consistent evidence of a relationship between adherence and IOP.
2
Failure to identify such a relationship could be explained by the lack of a quantified correlation, or could be attributed to the methodological quality of the studies examining such a correlation being poor. However, it is more likely that the complexities of assessing the level of IOP due to individual differences (types of glaucoma and diurnal variance), together with regression to the mean, lead to 'noisy data'.
The methodology used by Ajit et al 1 stated that 100 patients at their initial interview had their IOP recorded. However, no further discussion of the IOP data was done in the paper. Assuming that Ajit et al had the intention of collecting IOP data to study any relationship between IOP and adherence, it would be interesting if their findings could be published, particularly given the potential value to the glaucoma clinician of learning how IOP measures might correlate with adherence.
